ArticleNucleic acids research2026
A turn-on fluorescent nucleoside enabling sequence-insensitive DNA labeling.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Fluorescent nucleobase analogs (FBAs) are valuable tools for studying nucleic acid structure and dynamics. However, their utility is often limited by substantial fluorescence quenching upon incorporation into oligonucleotides and variable brightness influenced by neighboring bases. In this study, we present a novel turn-on nucleoside, 3b, a thiazolyl-dU analog (hereinafter referred as TzdU), engineered to overcome these limitations and enable reliable DNA fluorescence imaging. Compared to its nearly nonfluorescent free form, TzdU shows approximately a 10-fold increase in brightness in single-stranded DNA (ssDNA) and up to a 50-fold enhancement in double-stranded DNA (dsDNA). Importantly, it maintains relatively stable brightness regardless of surrounding bases by evading common quenching pathways, including solvent-induced collisional quenching and excited-state proton transfer (ESPT). The triphosphate derivative of TzdU is efficiently utilized by various DNA polymerases, including Deep Vent and KOD XL, facilitating real-time, intensity-based monitoring of critical enzymatic processes such as PCR and primer extension without external labels. Furthermore, TzdU can illuminate DNA in a gradient manner, enabling the visualization and encryption of information. As the first FBA to achieve universal turn-on characteristics, sequence insensitivity, and compatibility with enzymatic reactions, TzdU serves as a novel tool for investigating nucleic acid dynamics and advancing fluorescence-based methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.